OR WAIT null SECS
March 13, 2018
The $11.6-billion acquisition strengthens Sanofi's position in hematology and specialty medicines.
March 06, 2018
The companies will work together to develop prescription digital therapeutics for patients with schizophrenia and multiple sclerosis.
The companies will join forces to develop next-generation ex vivo cell therapies in oncology.
February 15, 2018
The agency has approved a new treatment for a certain type of prostate cancer using novel clinical trial endpoint.
Researchers at the University of Illinois developed a method to transplant pancreatic islet cells from pigs more easily to treat type I diabetes.
February 06, 2018
Paratek has completed submission of two new drug applications for oral and intravenous omadacycline, a new antibiotic for pneumonia and skin infections.
January 30, 2018
The acquisition will strengthen Sanofi's R&D strategy and expands its franchise for rare blood disorders.
January 24, 2018
The acquisition would boost Sanofi's position in hematology and specialty medicines.
The acquisition builds on the companies' earlier collaboration to develop T-cell-based therapeutics.
January 16, 2018
The agency has expanded the indication of AstraZeneca’s anti-cancer drug to include treatment for breast cancer with a certain inherited genetic mutation.